Metsera, Inc. - Common Stock (NQ:MTSR)

Google Parent Alphabet Has $754 Million Invested in These 3 Hot Growth Stocks. Here's the 1 Wall Street Likes the Most. ↗

Topics Lawsuit

October 27, 2025

At least one of these stocks owned by Alphabet could be a great pick for aggressive investors.

2 Unstoppable Dividend Stocks Yielding More Than 4% That Income-Seeking Investors Will Want to Buy in November and Hold Forever ↗

October 25, 2025

Both companies are monsters in their industry and are poised to thrive.

HALPER SADEH LLC ENCOURAGES MTSR, HOLX, MRUS SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Topics Government Intellectual Property World Trade

October 23, 2025

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

Viking Therapeutics Ignites Retail-Trader Frenzy Amid Deal Speculation, Upcoming Trial Catalysts ↗

October 06, 2025

Via Stocktwits

Metsera Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Metsera, Inc. - MTSR

October 23, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

2 Mega-Dividend Stocks With Yields As High As 7% ↗

October 21, 2025

Dividend stocks with high yields can be great investment opportunities, but those yields can also be red flags.

The company is readying to take on pharma giants Novo Nordisk and Eli Lilly.

Topics Economy Government Intellectual Property

Down 44%, Should You Buy the Dip on Viking Therapeutics? ↗

October 13, 2025

Pfizer is working hard to deal with some big headwinds it has coming up, but in five years, this should all be in the past.

Where Will Pfizer Be in 5 Years? ↗

October 13, 2025

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates PINC, MTSR, HOUS, ODP on Behalf of Shareholders

Topics Intellectual Property World Trade

October 07, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Premier, Inc. (Nasdaq – PINC), Metsera, Inc. (Nasdaq – MTSR), Anywhere Real Estate Inc. (NYSE – HOUS), The ODP Corporation (Nasdaq – ODP)

October 07, 2025

From Brodsky & Smith LLC

Pfizer's stock price is down materially from its 2021 highs, but it is also up notably from its April 2025 lows.

Down 50%, Should You Buy the Dip on Pfizer? ↗

October 07, 2025

After years of underperformance, the future is looking brighter for the drugmaker.

Topics Intellectual Property

3 Reasons to Buy Pfizer Stock Now ↗

October 06, 2025

2 Reliable Dividend Stocks With Yields Above 6% That You Can Buy With $100 in October ↗

October 03, 2025

You don't need to be rich to put your money to work on Wall Street.

Pfizer has an attractive 7.2% dividend yield, but there are some pros and cons you need to understand before you buy it.

Topics Intellectual Property

3 Things You Need to Know if You Buy Pfizer Today ↗

October 02, 2025

These stocks could see growth take off over the next few years.

Topics Intellectual Property

Got $200? 2 Healthcare Stocks to Buy and Hold Forever ↗

October 01, 2025

Metsera's MET-097i cut weight up to 14% in Phase 2b trials, with manageable side effects, as the company targets a global Phase 3 program in 2025.

Metsera Reports Up To 14% Weight Loss In Phase 2b Obesity Trial ↗

September 30, 2025

Via Benzinga

Pfizer Just Reminded Investors Why You Should Never Count Its Stock Out ↗

September 30, 2025

The company recently announced an acquisition that will bolster its growth prospects in the GLP-1 obesity market.

Metsera Reports Positive Phase 2b Results for First- and Best-in-Class Ultra-long Acting GLP-1 RA Candidate MET-097i, Enabling Rapid Transition into Phase 3

September 29, 2025

From Metsera, Inc.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PINC, MTSR, HOUS, ODP on Behalf of Shareholders

September 29, 2025

September 29, 2025

From Brodsky & Smith LLC

Right now, these dividend payers are top options for folks who like to set it and forget it.

3 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income ↗

September 29, 2025

Pfizer is facing a patent cliff and has a high payout ratio, but it is taking steps to get back on track.

Topics Artificial Intelligence Economy

Down 55%, Should You Buy the Dip on Pfizer? ↗

September 28, 2025

The company continues to improve its pipeline.

Topics Intellectual Property

Is Pfizer Stock a Buy After Its $5 Billion GLP-1 Bet? ↗

September 27, 2025

Pfizer is undergoing a new acquisition, exposing it to the weight loss market and additional revenue growth potential, which isn't priced in yet.

Pfizer is Locking in New Growth Through a New Acquisition ↗

September 26, 2025

Via MarketBeat

Topics Artificial Intelligence

Did Pfizer Just Give Investors 7 Billion Reasons to Buy Its Stock? ↗

September 26, 2025

The pharmaceutical giant is again plunging headfirst into weight-loss drug development.

These dividend stocks offer high yields and growth catalysts that could support payouts for decades.

Topics Intellectual Property

2 Top Passive Income Stocks to Buy Now ↗

September 26, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARIS, MTSR, GTLS, MURA on Behalf of Shareholders

Topics Bonds Economy Lawsuit

September 23, 2025

METSERA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Metsera, Inc. - MTSR

September 23, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARIS, MTSR, ODP, SMLR on Behalf of Shareholders

September 23, 2025